Cathepsin C Regulates Cytokine-Induced Apoptosis in β-Cell Model Systems.
Tina FløyelCaroline FrørupJoachim StørlingFlemming PociotPublished in: Genes (2021)
Emerging evidence suggests that several of the lysosomal cathepsin proteases are genetically associated with type 1 diabetes (T1D) and participate in immune-mediated destruction of the pancreatic β cells. We previously reported that the T1D candidate gene cathepsin H is downregulated by pro-inflammatory cytokines in human pancreatic islets and regulates β-cell function, apoptosis, and disease progression in children with new-onset T1D. In the present study, the objective was to investigate the expression patterns of all 15 known cathepsins in β-cell model systems and examine their role in the regulation of cytokine-induced apoptosis. Real-time qPCR screening of the cathepsins in human islets, 1.1B4 and INS-1E β-cell models identified several cathepsins that were expressed and regulated by pro-inflammatory cytokines. Using small interfering RNAs to knock down (KD) the cytokine-regulated cathepsins, we identified an anti-apoptotic function of cathepsin C as KD increased cytokine-induced apoptosis. KD of cathepsin C correlated with increased phosphorylation of JNK and p38 mitogen-activated protein kinases, and elevated chemokine CXCL10/IP-10 expression. This study suggests that cathepsin C is a modulator of β-cell survival, and that immune modulation of cathepsin expression in islets may contribute to immune-mediated β-cell destruction in T1D.
Keyphrases
- induced apoptosis
- endoplasmic reticulum stress
- oxidative stress
- signaling pathway
- single cell
- type diabetes
- poor prognosis
- cell therapy
- endothelial cells
- cell death
- cardiovascular disease
- young adults
- stem cells
- gene expression
- adipose tissue
- mesenchymal stem cells
- pi k akt
- cell cycle arrest
- transcription factor
- copy number
- binding protein
- genome wide
- weight loss
- glycemic control
- genome wide identification